MMJ PhytoTech Limited (ASX:MMJ) has raised A$4 million through the placement of 19,512,196 fully paid ordinary shares ("Placement") to institutional and sophisticated investors at $0.205 per share.
MMJ PhytoTech Ltd (ASX:MMJ) Directors present their report on the Consolidated Entity ("Group") consisting of MMJ PhytoTech Limited ("MMJ" or the "Company") (formerly PhytoTech Medical Ltd) and the entities it controlled at the end of, or during, the year ended 30 June 2016.
MMJ PhytoTech Ltd (ASX:MMJ) is pleased to provide the latest Investor Presentation regarding MMJ Brands to List on TSX-V via RTO.
MMJ PhytoTech Ltd (ASX:MMJ) is pleased to advise that it is set to unlock significant value for shareholders through the spin out of its core cannabis subsidiaries, United Greeneries Holdings Ltd and Satipharm AG, on the TSX-V.
The Traditional Therapy Clinics Ltd (ASX:TTC) Directors present their report, together with the financial statements, on the consolidated entity consisting of Traditional Therapy Clinics Limited and the entities it controlled at the end of, or during, the half-year ended 30 June 2016.
MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that its wholly-owned, Israeli-based subsidiary PhytoTech Therapeutics Limited ("PTL"), will commence a Phase 2 clinical study into the efficacy of the its PTL101 capsules in treating intractable epilepsy in children.
MMJ PhytoTech Limited (ASX:MMJ) ("MMJ" or "the Company") is pleased to advise that Catherine Harvey has been appointed as Chief Operations Officer, effective 1 September 2016.
